The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIWG Regulatory News (IWG)

Share Price Information for IWG (IWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 186.20
Bid: 186.40
Ask: 186.60
Change: 2.40 (1.31%)
Spread: 0.20 (0.107%)
Open: 182.50
High: 188.70
Low: 182.50
Prev. Close: 183.80
IWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - IWG PLC

25 Jun 2018 13:34

Norges Bank - Form 8.3 - IWG PLC

Norges Bank - Form 8.3 - IWG PLC

PR Newswire

London, June 25

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Norges Bank
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeIWG PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosureDealing Disclosure 22/06/2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No Not Required

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:1P ordinary
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:19,542,5592.14
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:19,542,5592.14

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
1P ordinarySell85,020GBP 3.1644

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:25/06/2018
Contact name:Philippe Chiaroni
Telephone number:+47 2407 3297

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
3rd Sep 20199:21 amRNSTotal Voting Rights: Month End Disclosure
29th Aug 20197:00 amRNSTransaction in Own Shares
28th Aug 20197:00 amRNSTransaction in Own Shares
27th Aug 20197:00 amRNSTransaction in Own Shares
23rd Aug 201910:33 amRNSTransaction in Own Shares
19th Aug 20197:09 amRNSTransaction in Own Shares
16th Aug 20197:00 amRNSTransaction in Own Shares
15th Aug 20197:00 amRNSTransaction in Own Shares
9th Aug 20197:00 amRNSStrategic Partnership Transaction in Taiwan
8th Aug 20197:10 amRNSTransaction in Own Shares
6th Aug 20197:15 amRNSShare repurchase programme
6th Aug 20197:00 amRNSInterim Results Announcment
1st Aug 20198:00 amRNSTotal Voting Rights: Month End Disclosure
11th Jul 20199:00 amRNSNotice of Results
1st Jul 201910:04 amRNSTotal Voting Rights: Month End Disclosure
25th Jun 20197:00 amRNSDirector/PDMR Shareholding
18th Jun 20197:00 amRNSDirector/PDMR Transaction
17th Jun 20197:00 amRNSDirector/PDMR Transaction
4th Jun 20197:00 amRNSTR-1: Notification of major holdings
3rd Jun 20197:00 amRNSTotal Voting Rights: Month End Disclosure
31st May 201911:31 amRNSCompletion of Strategic Partnership Transaction
14th May 201912:17 pmRNSResult of AGM
1st May 20197:05 amRNSTotal Voting Rights: Month End Disclosure
1st May 20197:00 amRNSTrading Statement
24th Apr 20199:00 amRNSNotification of 2019 Q1 Trading Statement
15th Apr 20197:00 amRNSStrategic Partnership Transaction in Japan
11th Apr 20195:05 pmRNSAnnual Report & Accounts, & Annual General Meeting
1st Apr 201911:04 amRNSTotal Voting Rights
8th Mar 201910:00 amRNSDirector/PDMR Transaction
8th Mar 201910:00 amRNSDirector/PDMR Transaction
6th Mar 20197:00 amRNSAnnual Financial Report Announcement
1st Mar 20197:00 amRNSTotal Voting Rights: Month End Disclosure
28th Feb 201910:36 amRNSDirectorate Change
1st Feb 201912:06 pmRNSTotal Voting Rights: Month End Disclosure
9th Jan 20197:00 amRNSStandard form for notification of major holdings
2nd Jan 20197:00 amRNSTotal Voting Rights: Month End Disclosure
28th Dec 20187:30 amRNSTransaction in Own Shares
24th Dec 201810:00 amRNSAppointment of Chief Financial Officer
20th Dec 20187:30 amRNSTransaction in Own Shares
19th Dec 20187:30 amRNSTransaction in Own Shares
18th Dec 20187:30 amRNSTransaction in Own Shares
18th Dec 20187:00 amRNSDirector/PDMR Transaction
17th Dec 20187:30 amRNSTransaction in Own Shares
17th Dec 20187:00 amRNSDirector/PDMR Transaction
14th Dec 20189:57 amRNSDirector/PDMR Transaction
14th Dec 20187:30 amRNSTransaction in Own Shares
13th Dec 20188:15 amRNSDirector/PDMR Transaction
13th Dec 20187:30 amRNSTransaction in Own Shares
12th Dec 20187:30 amRNSTransaction in Own Shares
11th Dec 20187:30 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.